Dopaminergic System and Apathy in Alzheimer's Disease

Principal Investigator
Krista Lanctôt, PhD
Sunnybrook & Women's College Health Sciences Centre
Toronto, Ontario, Canada
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2003 - March 31, 2006
Grant ID
A2003236
Summary
Apathy, or the loss of motivation, occurs in up to 80% of patients with Alzheimer’s disease (AD). With a loss of motivation, patients are unable to carry out basic everyday tasks by themselves. Hence, the patients rely more on their caregivers, increasing not only the burden, but also the stress level of the caregiver. The underlying cause of apathy in AD has not yet been clarified. In the brain, there is an important system that regulates motivation, known as the Brain Reward System. Studies have shown that when people stop using drugs of abuse that stimulates the Brain Reward System, apathy is one of the main symptoms they develop. Dr. Lanctôt has hypothesized that the apathy that develops in AD may be due to a loss of rewarding effects from the Brain Reward System. In this study, the rewarding effects will be measured following a single dose of a drug that stimulates the Brain Reward System (dextroamphetamine). This will determine first, if patients with apathy will respond differently than patients without apathy, and second if the results from the Brain Reward System probe can be used to predict whether or not AD patients with apathy improve when treated. This study has the potential to improve the treatment of an important symptom that has not been adequately studied or treated.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD